By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jun 1, 2019/CPG
This guideline summarizes treatment recommendations for children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or enthesitis.
Jun 10, 2019/Test & Measure
FGA is a modification of the Dynamic Gait Index and was created to help decrease the ceiling effect and improve reliability.
Jul 30, 2019/Test & Measure
PASS is a client-centered, performance-based, criterion-referenced observational outcome measure that examines the patient’s and client’s ability to function safely and independently in the community. The tool assesses performance of functional mobility skills, basic activities of daily living (ADLs),
Jan 1, 2020/CPG
Suggests that task-specific walking training should be performed to improve walking speed and distance in those with acute-onset CNS injury although only at higher intensities or with augmented feedback.
May 17, 2021/CPG
This guideline revises the 2008 Royal Dutch Society for Physical Therapy (Koninklijk Nederlands Genootschap voor Fysiotherapie, KNGF) recommendations on the assessment and treatment of patients with rheumatoid arthritis.
Aug 1, 2021/CPG
This guideline developed by the Academy of Orthopaedic Physical Therapy of the American Physical Therapy Association provides recommendations for effective physical therapy evaluation, treatment, and management of individuals experiencing limitations in the ability to participate in work following injury
Jan 3, 2021/CPG
This guideline presents 10 areas for advancing inclusive practice in physical activity and sedentary behavior for people living with disability.
Apr 1, 2021/CPG
This guideline from the Academy of Neurologic Physical Therapy provides evidence on the effects of ankle-foot orthoses and functional electrical stimulation post-stroke.
Jul 12, 2021/Test & Measure
The Harris Infant Neuromotor Test (HINT) is a screening tool designed to identify neuromotor or cognitive/behavioral concerns in infants who are healthy or at high risk between the ages of 3 and 12 months.
Aug 4, 2021/Test & Measure
This summary reviews a questionnaire to measure self-efficacy and contains information on use of it to screen patients or clients in a general clinical setting and reviews the use of this questionnaire with adolescents and adults in a general clinical setting without regard to a specific diagnosis or